SAN FRANCISCO--(BUSINESS WIRE)--Expanding on its commitment to improve health outcomes for millions of lives, Vida Health announced a new app-based, coach-centered virtual congestive heart failure ...

The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...

Key opinion leaders provide an overview of the treatment gaps in the management of heart failure. John McMurray, MBChB: Although I said that we have had many successes in the treatment of heart ...

Counterpart Health, Inc., a subsidiary of Clover Health, released research indicating that its AI-powered platform, Counterpart Assistant (CA), significantly improves the management of congestive ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, ...

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Kerendia®▼(finerenone), a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), for the ...

Bayer has received MHRA approval for Kerendia (finerenone) for adults in the UK with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or above. Th ...